Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts
Clinical trial NCT04399577 · COMPLETED
Trial details
- NCT number
- NCT04399577
- Sponsor
- Zagazig University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2019-03-03
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.